Monocyte chemotactic protein-1 secretion and expression after Toxoplasma gondii infection in vitro depend on the stage of the parasite

FEMS Microbiology Letters

Volumn 214, Issue 1, 2002, Pages 45-49

  Brenier Pinchart, Marie Pierre ^a   Vigan, Inés ^b   Jouvin Marche, Evelyne ^b   Marche, Patrice Noél ^b   Pelet, Elisabeth ^a   Gross, Uwe ^c   Ambroise Thomas, Pierre ^a   Pelloux, Hervé ^a  

^a UNIV GRENOBLE ALPES   (France)

^b INSERM   (France)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Chemokines; Monocyte chemotactic protein 1; Parasite stage; Real time PCR; Strains; Toxoplasma gondii

Indexed keywords

MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIFE CYCLE; MOLECULAR BIOLOGY; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXOPLASMA GONDII;

TOXOPLASMA GONDII;

EID: 0037183392     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(02)00842-X     Document Type: Article

References (17)

1. Yap G.S., Sher A. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology. 201:1999;240-247.
2. Frenkel J.K., Escajadillo A. Cyst rupture as a pathogenic mechanism of Toxoplasma encephalitis. Am. J. Trop. Med. Hyg. 36:1987;517-522.
3. Frenkel J.K. Pathophysiology of toxoplasmosis. Parasitol. Today. 4:1988;273-278.
4. Hunter C.A., Remington J.S. Immunopathogenesis of toxoplasmic encephalitis. J. Infect. Dis. 170:1994;1057-1067.
5. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:2000;217-242.
6. Brenier-Pinchart M.P., Pelloux H., Derouich-Guergour D., Ambroise-Thomas P. Chemokines in host-protozoan-parasite interactions. Trends Parasitol. 17:2001;292-296.
7. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 12:2000;121-127.
8. Bliss S.K., Marshall A.J., Zhang Y., Denkers E.Y. Chemokines secretion of human cells in response to Toxoplasma gondii infection. Infect. Immun. 162:1999;7369-7375.
9. Brenier-Pinchart M.P., Pelloux H., Simon J., Ricard J., Bosson J.L., Ambroise-Thomas P. Toxoplasma gondii induces the secretion of Monocyte Chemotactic Protein-1 in human fibroblasts, in vitro. Mol. Cell. Biochem. 209:2000;79-87.
10. Denney C.F., Eckmann L., Reed S.L. Chemokines secretion of human cells in response to Toxoplasma gondii infection. Infect. Immun. 67:1999;1547-1552.
11. Khan I.A., Murphy P.M., Casciotti L., Scwartzman J.D., Collins J., Gao J.L., Yeamam G.R. Mice lacking the chemokine receptor CCR1 increased susceptibility to Toxoplasma gondii infection. J. Immunol. 166:2001;1930-1937.
12. Ricard J., Pelloux H., Pathak S., Pipy B., Ambroise-Thomas, P. TNF-α enhances Toxoplasma gondii cysts formation in human fibroblasts through the sphingomyelinase pathway. Cell Signal. 8:1996;439-442.
13. Darde, M.L. (1996) Biodiversity in Toxoplasma gondii. In: Current Topics in Microbiology and Immunology, Toxoplasma gondii (Gross, U., Ed.), pp. 27-41. Springer-Verlag, Berlin, Germany.
14. Pelloux H., Ricard J., Bracchi V., Marckowicz Y., Verna J.M., Ambroise-Thomas P. Tumor necrosis factor alpha, interleukin 1 alpha, and interleukin 6 mRNA expressed by human astrocytoma cells after infection by three different strains of Toxoplasma gondii. Parasitol. Res. 80:1994;271-276.
15. Makioka A., Suzuki Y., Kobayashi A. Recognition of tachyzoite and bradyzoite antigens of Toxoplasma gondii by infected hosts. Infect. Immun. 59:1991;2763-2766.
16. Van Der Ven A.J., Schoondermark-Van De Ven E.M., Camps W., Melchers W.J., Koopmans P.P., Van Der Meer J.W., Galama J.M. Anti-Toxoplasma effect of pyrimethamine, trimethoprim and sulphonamides alone and in combination: implications for therapy. J. Antimicrob. Chemoth. 38:1996;75-80.
17. Gross U., Bormuth H., Gaissmaier C., Dittrich C., Krenn V., Bohne W., Ferguson D.J. Monoclonal antibodies directed against Toxoplasma gondii suitable for studying tachyzoite-bradyzoite interconversion in vivo. Clin. Diagn. Lab. Immunol. 2:1995;542-548.